---
title: 'BA.1/BA.5 Immunogenicity, Reactogenicity, and Disease Activity after COVID-19
  Vaccination in Patients with ANCA-Associated Vasculitis: A Prospective Observational
  Cohort Study'
date: '2023-08-26'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/37632120/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20230827181309&v=2.17.9.post6+86293ac
source: heidelberg[Affiliation]
description: Emerging omicron subtypes with immune escape lead to inadequate vaccine
  response with breakthrough infections in immunocompromised individuals such as Anti-neutrophil
  Cytoplasmic Antibody (ANCA)-associated vasculitis (AAV) patients. As AAV is considered
  an orphan disease, there are still limited data on SARS-CoV-2 vaccination and prospective
  studies that have focused exclusively on AAV patients are lacking. In addition,
  there are safety concerns regarding the use of highly immunogenic ...
disable_comments: true
---
Emerging omicron subtypes with immune escape lead to inadequate vaccine response with breakthrough infections in immunocompromised individuals such as Anti-neutrophil Cytoplasmic Antibody (ANCA)-associated vasculitis (AAV) patients. As AAV is considered an orphan disease, there are still limited data on SARS-CoV-2 vaccination and prospective studies that have focused exclusively on AAV patients are lacking. In addition, there are safety concerns regarding the use of highly immunogenic ...